|
1
|
Bellora F, Castriconi R, Dondero A,
Carrega P, Mantovani A, Ferlazzo G, Moretta A and Bottino C: Human
NK cells and NK receptors. Immunol Lett. 161:168–173. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gasser S and Raulet DH: Activation and
self-tolerance of natural killer cells. Immunol Rev. 214:130–142.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bae DS, Hwang YK and Lee JK: Importance of
NKG2D-NKG2D ligands interaction for cytolytic activity of natural
killer cell. Cell Immunol. 276:122–127. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kruse PH, Matta J, Ugolini S and Vivier E:
Natural cytotoxicity receptors and their ligands. Immunol Cell
Biol. 92:221–229. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yin X, Lu X, Zhang X, Min Z, Xiao R, Mao Z
and Zhang Q: Role of NKG2D in cytokine-induced killer cells against
lung cancer. Oncol Lett. 13:3139–3143. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mayes K, Elsayed Z, Alhazmi A, Waters M,
Alkhatib SG, Roberts M, Song C, Peterson K, Chan V, Ailaney N, et
al: BPTF inhibits NK cell activity and the abundance of natural
cytotoxicity receptor co-ligand. Oncotarget. 8:64344–64357. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Borchers MT, Harris NL, Wesselkamper SC,
Vitucci M and Cosman D: NKG2D ligands are expressed on stressed
human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol.
291:L222–L231. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Burgess SJ, Maasho K, Masilamani M,
Narayanan S, Borrego F and Coligan JE: The NKG2D receptor:
Immunobiology and clinical implications. Immunol Res. 40:18–34.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Coudert JD and Held W: The role of the
NKG2D receptor for tumor immunity. Semin Cancer Biol. 16:333–343.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Champsaur M and Lanier LL: Effect of NKG2D
ligand expression on host immune responses. Immunol Rev.
235:267–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stern-Ginossar N, Elefant N, Zimmermann A,
Wolf DG, Saleh N, Biton M, Horwitz E, Prokocimer Z, Prichardi M,
Hahn G, et al: Host immune system gene targeting by a viral miRNA.
Science. 317:376–381. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bauer S, Groh V, Wu J, Steinle A, Phillips
JH, Lanier LL and Spies T: Activation of NK cells and T cells by
NKG2D, a receptor for stress-inducible MICA. Science. 285:727–729.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fionda C, Soriani A, Malgarini G, Iannitto
ML, Santoni A and Cippitelli M: Heat shock protein-90 inhibitors
increase MHC class I-related chain A and B ligand expression on
multiple myeloma cells and their ability to trigger NK cell
degranulation. J Immunol. 183:4385–4394. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Haque M, Ueda K, Nakano K, Hirata Y,
Parravicini C, Corbellino M and Yamanishi K: Major
histocompatibility complex class I molecules are down-regulated at
the cell surface by the K5 protein encoded by Kaposi's
sarcoma-associated herpesvirus/human herpesvirus-8. J Gen Virol.
82:1175–1180. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Friese MA, Wischhusen J, Wick W, Weiler M,
Eisele G, Steinle A and Weller M: RNA interference targeting
transforming growth factor-beta enhances NKG2D-mediated antiglioma
immune response, inhibits glioma cell migration and invasiveness,
and abrogates tumorigenicity in vivo. Cancer Res.
64:7596–7603. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nachmani D, Stern-Ginossar N, Sarid R and
Mandelboim O: Diverse herpesvirus microRNAs target the
stress-induced immune ligand MICB to escape recognition by natural
killer cells. Cell Host Microbe. 5:376–385. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lanier LL: NKG2D receptor and its ligands
in host defense. Cancer Immunol Res. 3:575–582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stern-Ginossar N, Gur C, Biton M, Horwitz
E, Elboim M, Stanietsky N, Mandelboim M and Mandelboim O: Human
microRNAs regulate stress-induced immune responses mediated by the
receptor NKG2D. Nat Immunol. 9:1065–1073. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Morisaki T, Onishi H and Katano M: Cancer
immunotherapy using NKG2D and DNAM-1 systems. Anticancer Res.
32:2241–2247. 2012.PubMed/NCBI
|
|
20
|
Tallerico R, Todaro M, Di FS, Maccalli C,
Garofalo C, Sottile R, Palmieri C, Tirinato L, Pangigadde PN and La
Rocca R: Human NK cells selective targeting of colon
cancer-initiating cells: A role for natural cytotoxicity receptors
and MHC class I molecules. J Immunol. 190:2381–2390. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu J, Song Y, Bakker AB, Bauer S, Spies T,
Lanier LL and Phillips JH: An activating immunoreceptor complex
formed by NKG2D and DAP10. Science. 285:730–732. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Butler JE, Moore MB, Presnell SR, Chan HW,
Chalupny NJ and Lutz CT: Proteasome regulation of ULBP1
transcription. J Immunol. 182:6600–6609. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang C, Wang Y, Zhou Z, Zhang J and Tian
Z: Sodium butyrate upregulates expression of NKG2D ligand MICA/B in
HeLa and HepG2 cell lines and increases their susceptibility to NK
lysis. Cancer Immunol Immunother. 58:1275–1285. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maniar A, Zhang X, Lin W, Gastman BR,
Pauza CD, Strome SE and Chapoval AI: Human gammadelta T lymphocytes
induce robust NK cell-mediated antitumor cytotoxicity through CD137
engagement. Blood. 116:1726–1733. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Singh NP, Mccoy MT, Tice RR and Schneider
EL: A simple technique for quantitation of low levels of DNA damage
in individual cells. Exp Cell Res. 175:184–191. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang KF, Ren H, Cao J, Zeng GL, Xie J,
Chen M, Wang L and He CX: Decreased dicer expression elicits DNA
damage and up-regulation of MICA and MICB. J Cell Biol.
182:233–239. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Venkataraman GM, Suciu D, Groh V, Boss JM
and Spies T: Promoter region architecture and transcriptional
regulation of the genes for the MHC class I-Related chain a and b
ligands of NKG2D. J Immunol. 178:961–969. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bartek J, Bartkova J and Lukas J: DNA
damage signalling guards against activated oncogenes and tumour
progression. Oncogene. 26:7773–7779. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gasser S, Orsulic S, Brown EJ and Raulet
DH: The DNA damage pathway regulates innate immune system ligands
of the NKG2D receptor. Nature. 436:1186–1190. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ljunggren HG and Malmberg KJ: Prospects
for the use of NK cells in immunotherapy of human cancer. Nat Rev
Immunol. 7:329–339. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu J, Shen W, Tang Y, Zhou J, Li M, Zhu
W, Yang H, Wu J, Zhang S and Cao J: Proteasome inhibitor MG132
enhances the antigrowth and antimetastasis effects of radiation in
human nonsmall cell lung cancer cells. Tumour Biol. 35:7531–7539.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang L, Tang H, Kou Y, Li R, Zheng Y,
Wang Q, Zhou X and Jin L: MG132-mediated inhibition of the
ubiquitin-proteasome pathway ameliorates cancer cachexia. J Cancer
Res Clin Oncol. 139:1105–1115. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Winter M, Sombroek D, Dauth I,
Moehlenbrink J, Scheuermann K, Crone J and Hofmann TG: Control of
HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases
ATM and ATR. Nat Cell Biol. 10:812–824. 2008. View Article : Google Scholar : PubMed/NCBI
|
